Currently, there is only one drug in this class of medicationstirzepatide, which is approved as Mounjaro for treatment of Type 2 diabetes and as Zepbound for the treatment of obesity
Youll see a board-certified rheumatologist in days, not months, via telehealth across 20+ states with no referral required
The Journal of Endocrinology, 217 (3), R25R45
Nausea and vomiting: Nausea is the most frequently reported side effect, affecting up to 50% of patients taking GLP-1 drugs
While quite efficacious, these medications are quite expensive, with list prices ranging from $12,000 annually to roughly $16,000 annually as of March 2025, according to the September budget request from the states health and human services office